Oncology

Cancer cells
#Cancer research #CAR-T #Gene mutation #Genetics / genomics #Immunotherapy #Interview #Mass spectrometry / NMR #Meet the Researcher #Nautilus #Oncology #Precision medicine #Protein chemistry / Proteomics #Rare cancers

Podcast: New ways of looking at effective cancer treatment

This is the latest episode of the free DDW narrated podcast, titled “New ways of looking at effective cancer treatment”, which covers three articles written for DDW Volume 24 – Issue 2, Spring 2023 of DDW. They are called: “3D Genomics and targeted cancer therapies”, “Democratising… Read More

#News

Blood cancer
#Blood cancer #CAR-T #Cell therapy #Haematology #Oncology #Phase I trial #Synthekine

Positive initial results from trial of CD19 CAR-T in blood cancers

Synthekine has announced positive initial results from a Phase I study of SYNCAR-001 + STK-009 for the treatment of relapsed or refractory CD19+ haematologic malignancies.  In the results presented from eight patients treated in the dose escalation portion of the study with a fixed SYNCAR-001 infusion of… Read More

#Cancer Research #News

Diamond Light Source's synchrotron
#Cancer Research Horizons #Diamond Light Source #Fragment-based drug discovery #Oncology #Partnership

UK partners establish fragment-based drug discovery programme

Cancer Research Horizons is partnering with Diamond Light Source, the UK’s national synchrotron, to build a world-leading fragment-based drug discovery programme.  Diamond Light Source accelerates electrons to near light speed, producing bright light that is directed into research instruments known as beamlines.   Cancer Research Horizons and its drug discovery site… Read More

#Business & Investment #Cancer Research #News

#Artificial intelligence (AI) #CAR-T #Drug discovery #Exosomes #Oncology #Weight loss

New DDW Highlights podcast: 9 December 2024

The latest episode of the DDW Highlights podcast is now available to listen to and watch below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week’s leading news stories all shine a light on… Read More

#News

#Artificial intelligence (AI) #CAR-T #Drug discovery #Exosomes #Oncology #Weight loss

This week in drug discovery (2-6 December) 

News round-up for 2-6 December by DDW Senior Digital Content Editor Diana Spencer. This week’s leading news stories all shine a light on innovation within drug discovery, including a potential ‘best-in-industry’ weight loss drug, a gold-based compound that shrinks tumours by 82%, and a second-generation CAR-T therapy. Read More

#News

#Immunocore Holdings #National Institute for Health and Care Excellence (NICE) #Oncology #Ophthalmology

UK’s NICE reverses decision on uveal melanoma therapy

Immunocore Holdings’ Kimmtrak (tebentafusp) has been recommended for funding through the National Health Service (NHS) in England by the National Institute for Health and Care Excellence (NICE).  NICE has recommended KIMMTRAK within its marketing authorisation for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma.   The recommendation overturns… Read More

#News #Regulatory

Machine learning concept
#Artificial intelligence (AI) #Financing #Oncology #Orakl Oncology #Spinout #Start-ups

€11m supports launch of AI-powered drug development platform

Orakl Oncology has announced an €11 million seed funding round, led by Singular, with support from Bpifrance including the Grand Prix i-Lab, and participation from existing investors.   The new funding will be used to accelerate the company's growth and support the launch of two new commercial products, O-Predict and O-Validate… Read More

#Business & Investment #News #Start-up Zone

Gold compound
#Drug resistance #Oncology #Ovarian cancer #RMIT University #Solid tumours

Gold-based drug slows tumour growth by 82%

Gold-based drugs can slow tumour growth in animals by 82% and target cancers more selectively than standard chemotherapy drugs, according to new research.  The study published in the European Journal of Medicinal Chemistry reveals a new gold-based compound that’s 27 times… Read More

#Cancer Research #Editor's Choice #News

CAR-T cells attacking a cancer cell
#CAR-T #Cell therapy #High throughput screening #Live cell analysis #Oncology #Webinar

Last chance: Optimising expansion conditions for CAR-T cells

The development of gene-modified cell therapies, particularly CAR-T cells, has transformed cancer treatment by offering personalised and potentially curative options. But how can you enhance the characterisation and expansion of CAR-T cells and address ‘on target, off tumour’ effects? Register now for this exclusive… Read More

Webinar date:
Supported by Sartorius
#News

CAR-T cells attack cancer cells
#Autolus #Blood cancer #CAR-T #Cell therapy #Leukaemia #Oncology #University College London

Next-generation therapy overcomes limitations of other CAR-T

A new chimeric antigen receptor T cell (CAR-T) therapy has delivered highly promising results in treating patients with relapsed/refractory B-cell acute lymphoblastic leukaemia (r/r B-ALL).  The FELIX clinical trial was led by researchers at University College London (UCL) and UCLH and sponsored by UCL spin-out Autolus Therapeutics. Read More

#Cancer Research #Editor's Choice #News

#Brain cancer #Genetic profiling #Machine learning #Oncology #Precision medicine #UCLA

ML study identifies new glioblastoma treatment strategy

A new precision medicine approach that combines genetic and functional profiling could predict how glioblastoma will respond to therapy.  A new study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why glioblastoma becomes resistant to treatment and introduces a new approach that paves… Read More

#Cancer Research #Editor's Choice #News

#Cancer research #Drug development #Drug discovery #Immune system #Immunotherapy #Life sciences #Lithuania #Oncology #Start-ups #Tumour biology #Tumours

New podcast: Exciting start-ups and developments in drug discovery

This is the latest episode of the free DDW narrated podcast, titled ‘Exciting start-ups and developments in drug discovery’, which covers two articles written for DDW Volume 24 – Issue 1, Winter 2022/2023. They are called: ‘What Lithuania offers life sciences start-ups’ and ‘… Read More

#News

FDA
#Bispecific Antibodies #FDA #Jazz Pharmaceuticals #Oncology

Bispecific antibody gets accelerated FDA approval for biliary tract cancer

The Food and Drug Administration (FDA) has granted accelerated approval to Jazz Pharmacuticals’ zanidatamab-hrii (Ziihera) a bispecific HER2-directed antibody.  It is approved for previously treated, unresectable or metastatic HER2-positive (IHC 3+) biliary tract cancer (BTC), as detected by an FDA-approved test.  The FDA also approved VENTANA PATHWAY anti-HER-2/neu (4B5) Rabbit… Read More

#News #Regulatory

CAR-T therapy
#CAR-T #Cell therapy #High throughput screening #Live cell analysis #Oncology #Webinar

Register now: Learn techniques for optimising CAR-T expansion

The development of gene-modified cell therapies, particularly CAR-T cells, has transformed cancer treatment by offering personalised and potentially curative options. But how can you enhance the characterisation and expansion of CAR-T cells and address ‘on target, off tumour’ effects? Register now for this exclusive… Read More

Webinar date:
Supported by Sartorius
#News

#Cancer therapeutics #Cancer vaccine #Immunotherapy #mRNA-based vaccines #Oncology

A deep dive into cancer vaccines

Megan Thomas explores the innovation and opportunity for cancer vaccines with Dr Alexander Zehnder, CEO of CureVac, and Dr Chris Haqq, Chief Medical Officer of Elicio Therapeutics. It could be argued that Covid-19 gave us a boost to start making headway in cancer vaccines. Between the acceleration of mRNA vaccine… Read More

#Cancer Research #Exclusive Content

#Antibiotics #Autoimmune disease #Genetics / genomics #Oncology #Painkillers #T cell engagers

New DDW Highlights podcast: 25 November 2024

The latest episode of the DDW Highlights podcast is now available to listen to and watch below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week’s most exciting news stories all represent innovative solutions to the… Read More

#News